We therefore speculate that M-CSF-driven proliferation of CD163+ TAMs may be potentiated by T cell attack on melanoma cells, leading to increased expression of PD-L1, PD-L2 and other immune-suppressive molecules in the TME. The gene discussed is CD163; the disease is melanoma.